Collagen Stimulator Comparison
Ellansé and Sculptra are both collagen-stimulating injectables, but they are made from different materials and behave differently after treatment. Their physical properties influence how Dr. CK considers each one within a facial treatment plan; neither is universally better for every face or objective.
PCL and PLLA
| Comparison | Ellansé | Sculptra |
|---|---|---|
| Material | PCL microspheres in a CMC carrier gel | PLLA particles prepared as a diluted injectable |
| Physical characteristics | A firmer, mouldable injectable with an immediate support component | A diluted injectable designed for distribution across an appropriate treatment area |
| How results develop | Immediate physical support from the carrier gel, followed by progressive collagen stimulation | Early treatment-related fullness settles before collagen-related improvement develops gradually |
| Structural support role | May be selected for deeper support, projection and precise contouring | Not usually selected to create the same firm, precisely moulded structural contour |
| Collagen-stimulation role | Collagen stimulation develops around the PCL microspheres | PLLA stimulates a gradual collagen response across the treated tissue |
| Treatment-planning differences | Often considered for selected deeper structural points and defined contours | Often considered for broader, more superficial collagen stimulation where appropriate |
| Reversibility considerations | It is not dissolved in the same way as hyaluronic acid filler | It is not dissolved in the same way as hyaluronic acid filler |
PCL + CMC
Ellansé contains polycaprolactone, or PCL, microspheres suspended in a carboxymethyl cellulose, or CMC, carrier gel. The carrier contributes immediate physical support after placement. The PCL component then supports a progressive collagen response over time.
Because the material has a firmer, mouldable character, it may be considered for selected deeper structural points where support, projection or a precisely defined contour is the treatment objective.
PLLA
Sculptra contains poly-L-lactic acid, or PLLA. It is prepared as a diluted injectable and distributed through an appropriate tissue plane according to the treatment objective. Temporary early fullness from fluid is not the final result.
As that fluid settles, collagen-related change develops progressively. Dr. CK may consider Sculptra when broader or more superficial collagen stimulation is appropriate rather than when a firm, immediately moulded contour is required.
Treatment planning
Within Dr. CK’s approach, Ellansé is primarily considered for deeper structural support and selected precise contouring. Sculptra may be considered for broader or more superficial collagen stimulation where that better matches the tissue level and treatment objective.
Treatment selection depends on facial anatomy, the tissue level that requires attention, previous treatments, the treatment objective and the expected outcome. A product name alone does not determine the appropriate plan.
Different modalities may sometimes be selected for different tissue levels or objectives within a staged plan. For example, one area may require deeper structural support while another may benefit from broader collagen stimulation. Whether treatments should be combined, separated or not used is determined only after clinical assessment.
Neither Ellansé nor Sculptra is dissolved in the same way as hyaluronic acid filler. This distinction matters during product selection, particularly when previous treatment, anatomy or the desired degree of adjustability needs to be considered. Learn more about HA filler and reversibility.
The appropriate injectable depends on what the face needs rather than which product is more familiar. A consultation should consider facial structure, ageing pattern, skin and tissue quality, previous procedures, treatment priorities and whether the objective is support, contour, collagen stimulation or a combination.
Some people may be suitable for one treatment, a staged combination or neither. The treatment plan and sequence should be decided after an individual medical assessment.
Individual assessment
A doctor-led consultation helps identify the tissue level, treatment objective and modality that may be appropriate for you.
Book a Consultation